Article
Automated machine learning to predict the co-occurrence of isocitrate dehydrogenase mutations and O6 -methylguanine-DNA methyltransferase promoter methylation in patients with gliomas.
Journal of magnetic resonance imaging : JMRI - 1 Jul 2021
Zhang Simin, Sun Huaiqiang, Su Xiaorui, Yang Xibiao, Wang Weina, Wan Xinyue, Tan Qiaoyue, Chen Ni, Yue Qiang, Gong Qiyong
Abstract excerpt
Combining isocitrate dehydrogenase mutation (IDHmut) with O6 -methylguanine-DNA methyltransferase promoter methylation (MGMTmet) has been identified as a critical prognostic molecular marker for gliomas. The aim of this study was to determine the ability of glioma radiomics features from magnetic resonance imaging (MRI) to predict the co-occurrence of IDHmut and MGMTmet by applying the tree-based pipeline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.